Rockefeller Capital Management L.P. raised its stake in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 61.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,491 shares of the company’s stock after buying an additional 5,541 shares during the period. Rockefeller Capital Management L.P.’s holdings in HealthEquity were worth $1,328,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also added to or reduced their stakes in the company. Acumen Wealth Advisors LLC purchased a new position in shares of HealthEquity during the fourth quarter worth approximately $27,000. Caitong International Asset Management Co. Ltd boosted its holdings in shares of HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after purchasing an additional 293 shares during the period. Aster Capital Management DIFC Ltd bought a new position in HealthEquity in the fourth quarter worth approximately $28,000. Torren Management LLC purchased a new position in HealthEquity during the 4th quarter worth $40,000. Finally, Northwestern Mutual Wealth Management Co. increased its holdings in HealthEquity by 190.4% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 604 shares of the company’s stock worth $55,000 after purchasing an additional 396 shares during the period. 99.55% of the stock is currently owned by institutional investors.
HealthEquity Stock Performance
Shares of NASDAQ:HQY opened at $92.29 on Thursday. The firm has a 50 day moving average of $85.57 and a 200 day moving average of $84.61. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $7.72 billion, a price-to-earnings ratio of 34.57, a price-to-earnings-growth ratio of 1.52 and a beta of 0.21. HealthEquity, Inc. has a 52 week low of $72.76 and a 52 week high of $105.96.
Insider Activity at HealthEquity
In related news, EVP Michael Henry Fiore sold 3,142 shares of the firm’s stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the sale, the executive vice president owned 59,113 shares of the company’s stock, valued at $5,615,735. This trade represents a 5.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director owned 19,733 shares in the company, valued at $1,775,970. This trade represents a 11.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 13,081 shares of company stock valued at $1,193,000 over the last quarter. 1.60% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on the company. Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. Barrington Research restated an “outperform” rating and set a $110.00 price target on shares of HealthEquity in a research note on Friday, May 22nd. Deutsche Bank Aktiengesellschaft lifted their price objective on HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a report on Thursday, March 19th. BMO Capital Markets raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $85.00 to $105.00 in a research note on Thursday, April 9th. Finally, Royal Bank Of Canada increased their target price on shares of HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a report on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, HealthEquity currently has an average rating of “Moderate Buy” and an average price target of $110.57.
Check Out Our Latest Analysis on HealthEquity
HealthEquity Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Read More
- Five stocks we like better than HealthEquity
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
